Literature DB >> 1958089

Drug interactions in arthritic patients.

I E Buchan1, H A Bird.   

Abstract

The drug treatment of 100 consecutive new patients admitted to a regional rheumatology centre was reviewed. Potential drug interactions actions were sought according to appendix one of the British National Formulary (September 1989) and identified in 55 of 100 patients. The clinical and laboratory features of these patients were then reviewed, showing that only 11 displayed clinical manifestations of a drug interaction. Five patients had drug induced drowsiness, which was easily corrected, five a raised serum creatinine, which was less easily corrected, and one both. Although there is considerable potential for drug interaction in patients with severe arthritis, the proportion of patients who display clinical manifestations of this is small.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958089      PMCID: PMC1004529          DOI: 10.1136/ard.50.10.680

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  2 in total

Review 1.  The kidney in rheumatic diseases.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

2.  Renal proximal dysfunction in patients with rheumatic diseases.

Authors:  H A Bird; H Yu; E H Cooper
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07
  2 in total
  4 in total

1.  Potential for drug interactions in elderly patients with arthritis.

Authors:  T Hunter
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

Review 2.  Drug management of arthritis in the elderly.

Authors:  A Fleming
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

Review 3.  Drug interactions between prescribed and over-the-counter medication.

Authors:  P K Honig; B K Gillespie
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

Review 4.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.